Sergi Clavé

516 total citations
26 papers, 365 citations indexed

About

Sergi Clavé is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Sergi Clavé has authored 26 papers receiving a total of 365 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Sergi Clavé's work include Lung Cancer Treatments and Mutations (18 papers), Cancer Genomics and Diagnostics (7 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Sergi Clavé is often cited by papers focused on Lung Cancer Treatments and Mutations (18 papers), Cancer Genomics and Diagnostics (7 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Sergi Clavé collaborates with scholars based in Spain, United Kingdom and United States. Sergi Clavé's co-authors include Edurne Arriola, Marta Salido, Álvaro Taus, Joan Albanell, Lara Pijuán, Sílvia Menéndez, Marta Lorenzo, Pedro Rocha, David Casadevall and Blanca Espinet and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Annals of Oncology.

In The Last Decade

Sergi Clavé

23 papers receiving 363 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sergi Clavé Spain 10 221 207 117 76 37 26 365
Connie W. C. Hui Hong Kong 11 154 0.7× 129 0.6× 63 0.5× 157 2.1× 54 1.5× 21 389
Yung‐Bin Kuo Taiwan 11 81 0.4× 112 0.5× 90 0.8× 133 1.8× 34 0.9× 15 340
Lucia Da Ros Italy 9 142 0.6× 114 0.6× 135 1.2× 104 1.4× 17 0.5× 23 332
Alessandro Dal Maso Italy 10 200 0.9× 286 1.4× 99 0.8× 71 0.9× 27 0.7× 25 388
R. Di Marsico Italy 5 154 0.7× 235 1.1× 130 1.1× 145 1.9× 29 0.8× 10 356
Samir Darwish Italy 12 311 1.4× 250 1.2× 88 0.8× 116 1.5× 38 1.0× 17 441
Erik Škof Slovenia 11 48 0.2× 173 0.8× 44 0.4× 60 0.8× 75 2.0× 34 347
Hongyan Zai China 11 61 0.3× 101 0.5× 98 0.8× 144 1.9× 71 1.9× 26 321
C. K. Park South Korea 8 165 0.7× 116 0.6× 44 0.4× 87 1.1× 156 4.2× 14 400
İbrahim Petekkaya Türkiye 10 83 0.4× 261 1.3× 121 1.0× 111 1.5× 22 0.6× 24 382

Countries citing papers authored by Sergi Clavé

Since Specialization
Citations

This map shows the geographic impact of Sergi Clavé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sergi Clavé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sergi Clavé more than expected).

Fields of papers citing papers by Sergi Clavé

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sergi Clavé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sergi Clavé. The network helps show where Sergi Clavé may publish in the future.

Co-authorship network of co-authors of Sergi Clavé

This figure shows the co-authorship network connecting the top 25 collaborators of Sergi Clavé. A scholar is included among the top collaborators of Sergi Clavé based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sergi Clavé. Sergi Clavé is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Unanua, N. Castro, Irune Ruiz, Sergi Clavé, et al.. (2024). 55P Differences in response to immune treatment between KRAS G12C and KRAS non-G12C mutated non-small cell lung cancer. ESMO Open. 9. 102634–102634.
2.
Clavé, Sergi, Marta Sesé, Rosa Somoza, et al.. (2023). 2223P Next-generation sequencing enables identification of RET rearrangements in papillary thyroid cancer. Annals of Oncology. 34. S1145–S1146. 1 indexed citations
3.
Kwon, Thérèsa, Sergi Clavé, Christine Piètrement, et al.. (2022). Outbreak of hemolytic uremic syndrome with unusually severe clinical presentation caused by Shiga toxin-producing Escherichia coli O26:H11 in France. Archives de Pédiatrie. 29(6). 448–452. 9 indexed citations
4.
Taus, Álvaro, Pedro Rocha, Ainhoa Hernández, et al.. (2021). Plasmatic KRAS Kinetics for the Prediction of Treatment Response and Progression in Patients With KRAS-mutant Lung Adenocarcinoma. Archivos de Bronconeumología. 57(5). 323–329. 2 indexed citations
5.
Taus, Álvaro, Pedro Rocha, Ainhoa Hernández, et al.. (2020). Plasmatic KRAS Kinetics for the Prediction of Treatment Response and Progression in Patients With KRAS-mutant Lung Adenocarcinoma. Archivos de Bronconeumología. 57(5). 323–329. 2 indexed citations
6.
Clavé, Sergi, Lara Pijuán, Marta Lorenzo, et al.. (2019). Next-generation Sequencing for ALK and ROS1 Rearrangement Detection in Patients With Non–small-cell Lung Cancer: Implications of FISH-positive Patterns. Clinical Lung Cancer. 20(4). e421–e429. 33 indexed citations
7.
Sánchez-Martín, Francisco Javier, Oriol Arpí, Laura Visa, et al.. (2019). HER-Family Ligands Promote Acquired Resistance to Trastuzumab in Gastric Cancer. Molecular Cancer Therapeutics. 18(11). 2135–2145. 42 indexed citations
8.
Clavé, Sergi, Beatríz Bellosillo, Marta Salido, et al.. (2019). P2.09-34 Next-Generation Sequencing Implementation in Non-Small Cell Lung Cancer Molecular Diagnosis. Journal of Thoracic Oncology. 14(10). S783–S783. 1 indexed citations
9.
Clavé, Sergi, Marta Salido, Pedro Rocha, et al.. (2019). Identification of MET gene amplifications using next-generation sequencing in non-small cell lung cancer patients. Annals of Oncology. 30. v800–v800. 4 indexed citations
10.
Clavé, Sergi, Álvaro Taus, Pedro Rocha, et al.. (2019). Concomitant genomic alterations in KRAS mutant advanced lung adenocarcinoma. Lung Cancer. 140. 42–45. 14 indexed citations
11.
Taus, Álvaro, Pedro Rocha, Lara Pijuán, et al.. (2018). Dynamics of EGFR Mutation Load in Plasma for Prediction of Treatment Response and Disease Progression in Patients With EGFR-Mutant Lung Adenocarcinoma. Clinical Lung Cancer. 19(5). 387–394.e2. 44 indexed citations
12.
Clavé, Sergi, Alba Dalmases, Raquel Longarón, et al.. (2017). P1.02-048 MET Exon 14 Skipping Mutations and Gene Amplifications Are Not Simultaneous Events in NSCLC. Journal of Thoracic Oncology. 12(1). S516–S517. 1 indexed citations
13.
Casadevall, David, Sergi Clavé, Álvaro Taus, et al.. (2017). Heterogeneity of Tumor and Immune Cell PD-L1 Expression and Lymphocyte Counts in Surgical NSCLC Samples. Clinical Lung Cancer. 18(6). 682–691.e5. 69 indexed citations
14.
Clavé, Sergi, David Casadevall, Lara Pijuán, et al.. (2016). 4P Co-amplifications of PD-L1/PD-L2 genes (9p24.1) and PD-L1 protein expression in NSCLC patients. Journal of Thoracic Oncology. 11(4). S58–S58. 2 indexed citations
15.
Clavé, Sergi, Alba Dalmases, Raquel Longarón, et al.. (2016). 11P Prognostic impact of MET mutations in exon 14 and copy number alterations in a series of NSCLC patients. Journal of Thoracic Oncology. 11(4). S61–S61. 1 indexed citations
16.
17.
Casadevall, David, Javier Gimeno, Sergi Clavé, et al.. (2015). MET expression and copy number heterogeneity in nonsquamous non-small cell lung cancer (nsNSCLC). Oncotarget. 6(18). 16215–16226. 49 indexed citations
18.
Joya, Xavier, et al.. (2015). Prenatal ethanol exposure and placental hCG and IGF2 expression. Placenta. 36(8). 854–862. 15 indexed citations
19.
Clavé, Sergi, et al.. (2014). Ethanol cytotoxic effect on trophoblast cells. Toxicology Letters. 225(2). 216–221. 20 indexed citations
20.
Clavé, Sergi, Javier Gimeno, Silvia de Muga, et al.. (2014). Ros1 Rearrangements and Copy Number Alterations in Nsclc Patients: High Frequency of Ros1 Deletions. Annals of Oncology. 25. iv566–iv566. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Connie W. C. Hui Breakdown of academic impact, for papers by Yung‐Bin Kuo Breakdown of academic impact, for papers by Lucia Da Ros Breakdown of academic impact, for papers by Alessandro Dal Maso Breakdown of academic impact, for papers by R. Di Marsico Breakdown of academic impact, for papers by Samir Darwish Breakdown of academic impact, for papers by Erik Škof Breakdown of academic impact, for papers by Hongyan Zai Breakdown of academic impact, for papers by C. K. Park Breakdown of academic impact, for papers by İbrahim Petekkaya
Rankless by CCL
2026